The biggest city in Switzerland, Zurich, is one of Europe’s top financial centers and home to the SIX Swiss Exchange (SWX). It’s also one of the most expensive cities in Europe to live in (as my Swiss colleague Claire could confirm). With so much money nearby, how does the local Biotech ecosystem looks like?
The biggest Biotech/mid-size Pharma in the area is Octopharma. Founded in 1983 and located Southwest of Zurich (on the other side of the Lake of Zurich), its human protein business generated €1.5Bn revenues in 2015 – talk about profitable.
Part of the history of Zurich’s Biotech ecosystem is marked by two particular acquisitions. Covagen and its multi-specific antibodies were acquired by Janssen in 2014. GlycoVaxyn (targeting bacterial infections) was acquired for $190M by GSK in 2015. Both were spin-outs of the Swiss Federal Institute of Technology (ETH Zurich).
Now, here’s our list of 9 Biotechs in the Zurich area you should know…